Endogenous anti-β-glucan antibodies as a potential predictive biomarker for clinical response to imprime PGG immunotherapy in non-small cell lung cancer (NSCLC) patients.
Nandita Bose
Employment or Leadership Position - Biothera
Stock Ownership - Biothera
Mary Antonysamy
Employment or Leadership Position - Biothera
Stock Ownership - Biothera
Myra Louise Patchen
Employment or Leadership Position - Biothera
Stock Ownership - Biothera
Jamie R. Lowe
Employment or Leadership Position - Biothera
Stock Ownership - Biothera
Paulette Mattson
Employment or Leadership Position - Biothera
Stock Ownership - Biothera
Michele Anne Gargano
Employment or Leadership Position - Biothera
Stock Ownership - Biothera
Keith Gorden
Employment or Leadership Position - Biothera
Stock Ownership - Biothera
Steven Leonardo
Employment or Leadership Position - Biothera (U)
Stock Ownership - Biothera
Richard Walsh
Employment or Leadership Position - Biothera
Stock Ownership - Biothera
Xiaohong Qui
Employment or Leadership Position - Biothera
Stock Ownership - Biothera
Nadine Ottoson
Employment or Leadership Position - Biothera
Stock Ownership - Biothera
Katie E. Ertelt
Employment or Leadership Position - Biothera
Stock Ownership - Biothera
Lindsay R. Wurst
Employment or Leadership Position - Biothera
Stock Ownership - Biothera
Diane McMurray
Employment or Leadership Position - biot
Stock Ownership - Biothera (B)
Anissa S.H. Chan
Employment or Leadership Position - Biothera
Stock Ownership - biot
Adria Jonas
Employment or Leadership Position - Biothera
Stock Ownership - Biothera
Richard Dale Huhn
Employment or Leadership Position - Biothera
Stock Ownership - Biothera
Michael Thomas
Research Funding - Biothera
Parvis Sadjadian
Research Funding - Biothera
Folker Schneller
Research Funding - Biothera